NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 00378-9116-16 — Nitroglycerin 24-hour skin patchAI (346 hospitals, 35,828–36,818 samples)
• NDC 00574-4144-35 — Neomycin, bacitracin, polymyxin and hydrocortisone eye ointmentAI (101 hospitals, 35,882–36,773 samples)
• NDC 00378-9070-16 — Rivastigmine 4.6 mg/24-hour transdermal patchAI (264 hospitals, 35,778–36,768 samples)
• NDC 00065-1795-04 — Balanced salt solution for eye surgeryAI (282 hospitals, 36,459–36,711 samples)
• NDC 00003-0293-20 — Kenalog-40 (triamcinolone) injectable suspension, 40 mg/mLAI (484 hospitals, 34,334–36,710 samples)
• NDC 24208-0295-25 — Tobramycin and dexamethasone eye drop suspensionAI (633 hospitals, 35,536–36,706 samples)
• NDC 00378-9123-98 — Fentanyl 72-hour skin patch, 75 mcg per hourAI (390 hospitals, 35,841–36,705 samples)
• NDC 61314-0355-01 — Tropicamide 1% eye dropsAI (720 hospitals, 35,427–36,678 samples)
• NDC 61314-0206-15 — Pilocarpine 4% eye drops, 15 mL bottleAI (650 hospitals, 35,610–36,627 samples)
• NDC 63323-0694-04 — Acetylcysteine 20% solutionAI (770 hospitals, 35,578–36,613 samples)
• NDC 00574-4022-35 — Bacitracin 500 unit per gram ointmentAI (455 hospitals, 35,606–36,605 samples)
• NDC 00409-2305-16 — Midazolam 2 mg per 2 mL injection syringeAI (349 hospitals, 31,501–36,595 samples)
• NDC 68462-0157-40 — Ondansetron 4 mg dissolving tabletAI (568 hospitals, 27,348–36,582 samples)
• NDC 47781-0585-68 — Ketorolac 60 mg intramuscular injectionAI (73 hospitals, 35,429–36,572 samples)
• NDC 00338-0322-01 — Recombinant thrombin solution, 5000 unitsAI (706 hospitals, 35,719–36,556 samples)
• NDC 61314-0630-06 — Neomycin, polymyxin, and dexamethasone eye dropsAI (837 hospitals, 35,368–36,493 samples)
• NDC 00009-3073-01 — Depo-Medrol 40 mg/mL steroid injectionAI (877 hospitals, 31,497–36,492 samples)
• NDC 00941-0409-06 — Peritoneal dialysis solution, 1.5% dextrose, 5 liter bagAI (134 hospitals, 36,456–36,492 samples)
• NDC 00527-6004-80 — Lidocaine 4% topical solutionAI (606 hospitals, 35,359–36,475 samples)
• NDC 17478-0201-02 — Phenylephrine 2.5% eye drops, 2 mL bottleAI (472 hospitals, 35,588–36,470 samples)
• NDC 70860-0700-01 — Ketorolac 15 mg/mL injectionAI (141 hospitals, 35,155–36,469 samples)
• NDC 17478-0701-02 — Indocyanine green injection vialAI (327 hospitals, 35,797–36,463 samples)
• NDC 00378-9116-93 — Nitroglycerin 24-hour skin patchAI (453 hospitals, 35,336–36,461 samples)
• NDC 00121-1154-00 — Lactulose 10 g/15 mL oral solutionAI (432 hospitals, 35,395–36,457 samples)
• NDC 00093-0262-15 — FLUOCINONIDE 0.05 % TOPICAL CREAMAI (319 hospitals, 35,511–36,438 samples)
• NDC 42571-0137-25 — Ketorolac eye dropsAI (545 hospitals, 35,297–36,431 samples)
• NDC 00338-0017-10 — 5% dextrose in water intravenous solutionAI (229 hospitals, 35,152–36,421 samples)
• NDC 51079-0285-20 — Diazepam 5 mg tablets, pack of 100AI (967 hospitals, 34,731–36,414 samples)
• NDC 00378-6470-99 — Scopolamine 1 mg patch, 72-hourAI (212 hospitals, 35,554–36,364 samples)
• NDC 00641-6146-10 — Dexamethasone sodium phosphate injectionAI (138 hospitals, 34,614–36,360 samples)
• NDC 25021-0418-82 — Tranexamic acid IV infusion in salineAI (364 hospitals, 35,161–36,331 samples)
• NDC 76329-3012-05 — Lidocaine 2% urethral jelly applicatorAI (607 hospitals, 35,139–36,318 samples)
• NDC 21922-0021-07 — Permethrin 5% creamAI (681 hospitals, 35,268–36,312 samples)
• NDC 00409-1631-10 — Calcium chloride injection 10%AI (510 hospitals, 35,723–36,308 samples)
• NDC 00517-2340-01 — Iron sucrose 100 mg IV solutionAI (608 hospitals, 34,945–36,304 samples)
• NDC 76329-3011-05 — Lidocaine 2% gel in prefilled syringe for urethral useAI (517 hospitals, 33,830–36,287 samples)
• NDC 00143-9391-10 — Remifentanil injection, 1 mgAI (276 hospitals, 34,990–36,277 samples)
• NDC 00406-9000-76 — Fentanyl 100 mcg/hr skin patchAI (244 hospitals, 35,544–36,264 samples)
• NDC 47781-0427-11 — Fentanyl 75 mcg/hr skin patchAI (354 hospitals, 35,227–36,253 samples)
• NDC 24208-0411-10 — BRIMONIDINE 0.2 % EYE DROPSAI (192 hospitals, 35,298–36,252 samples)
• NDC 70756-0605-25 — verapamil 2.5 mg/mL intravenous solutionAI (212 hospitals, 35,971–36,250 samples)
• NDC 24208-0411-05 — Brimonidine tartrate 0.2% eye dropsAI (650 hospitals, 35,056–36,235 samples)
• NDC 61314-0016-01 — Proparacaine eye drops 0.5%AI (883 hospitals, 34,730–36,224 samples)
• NDC 00093-2203-01 — metoclopramide 10 mg tabletAI (507 hospitals, 35,486–36,215 samples)
• NDC 70512-0843-01 — Ketorolac 30 mg/mL injection solutionAI (252 hospitals, 33,105–36,192 samples)
• NDC 55111-0688-52 — Zoledronic acid 5 mg intravenous infusionAI (735 hospitals, 34,679–36,173 samples)
• NDC 00641-6041-25 — Ketorolac 15 mg/mL injectionAI (140 hospitals, 34,994–36,137 samples)
• NDC 00641-6041-01 — Ketorolac 15 mg/mL injectionAI (97 hospitals, 34,992–36,117 samples)
• NDC 47781-0585-46 — Ketorolac 60 mg per 2 mL injectionAI (74 hospitals, 34,991–36,107 samples)
• NDC 47781-0583-93 — Ketorolac 15 mg/mL injectionAI (101 hospitals, 34,988–36,077 samples)